Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid

Annals of Neurology

Volumn 65, Issue 6, 2009, Pages 639-649

  Owens, Gregory P ^a   Bennett, Jeffrey L ^a   Lassmann, Hans ^b   O'Connor, Kevin C ^c   Ritchie, Alanna M ^a   Shearer, Andrew ^a   Lam, Chiwah ^a   Yu, Xiaoli ^a   Birlea, Marius ^a   DuPree, Cecily ^a   Williamson, R Anthony ^d   Hafler, David A ^c   Burgoon, Mark P ^a   Gilden, Don ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Medical University of Vienna   (Austria)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Calmune Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; OLIGOCLONAL BAND; PROTEOLIPID PROTEIN;

ARTICLE; B LYMPHOCYTE; BRAIN TISSUE; CELL CLONE; CELL GRANULE; CEREBROSPINAL FLUID; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE CLONE; MULTIPLE SCLEROSIS; NERVE CELL; PLASMA CELL; PRIORITY JOURNAL; TISSUE CULTURE CELL; TISSUE SECTION;

ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTE SUBSETS; CELL LINE; CELL PROLIFERATION; CLONE CELLS; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MULTIPLE SCLEROSIS; PLASMA CELLS; RECOMBINANT PROTEINS;

EID: 67650082863     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21641     Document Type: Article

References (50)

1. Gilden DH. Infectious causes of multiple sclerosis. Lancet Neurol 2006;4:195-202.
2. Cepok S, Rosche B, Grummel V, et al. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 2005;128:1667-1676.
3. Corcione A, Casazza S, Ferretti E, et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci U S A 2004;11064-11069.
4. Owens GP, Kraus H, Burgoon MP, et al. Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann Neurol 1998;43:236-243.
5. Qin Y, Duquette P, Zhang Y, et al. Clonal expansion and somatic hypermutation of VH genes of B cells from cerebrospinal fluid in multiple sclerosis. J Clin Invest 1998;102:1045-1050.
6. Baranzini SE, Jeong MC, Butunoi C, et al. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol 1999;163:5133-5144.
7. Colombo M, Dono M, Gazzola P, et al. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol 2000;164:2782-2789.
8. Ritchie AM, Gilden DH, Williamson RA, et al. Comparative analysis of the CD19+ and CD138+ cell antibody repertoires in the cerebrospinal fluid of patients with multiple sclerosis. J Immunol 2004;173:649-656.
9. Monson NL, Brezinchek HP, Brezinchek R, et al. Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients. J Neuroimmunol 2005;158:170-181.
10. Owens GP, Winges KM, Ritchie AM, et al. VH4 gene segments dominate the intrathecal humoral immune response in multiple sclerosis. J Immunol 2007;179:6343-6351.
11. Obermeier B, Mentele R, Malotka J, et al. Matching of the oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat Med 2008;6:688-693.
12. Burgoon MP, Keays KM, Owens GP, et al. Laser capture microdissection of plasma cells from SSPE brain reveals intrathecal disease-relevant antibodies. Proc Natl Acad Sci U S A 2005;102:7245-7250.
13. Owens GP, Ritchie AM, Gilden DH, et al. Measles virus-specific plasma cells are prominent in SSPE CSF. Neurology 2007;68:1815-1819.
14. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
15. Polman CH, Reingold SC, Eden G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58:840-846.
16. Yu X, Gilden DH, Ritchie AM, et al. Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide library. J Neuroimmunol 2006;172:121-131.
17. Deibler GE, Martenson RE, Kies MW. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep Biochem 1972;2:139-165.
18. O'Connor KC, Appel H, Bregoli L, et al. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J Immunol 2005;175:1974-1982.
19. Ponath PD, Kassam N, Qin S. Monoclonal antibodies to chemokine receptors. Methods Mol Biol 2000;138:231-242.
20. Greenfield EA, Reddy J, Lees A, et al. Monoclonal antibodies to distinct regions of human myelin proteolipid protein simultaneously recognize central nervous system myelin and neurons of many vertebrate species. J Neurosci Res 2006;83:415-431.
21. O'Connor KC, Nguyen K, Stollar BD. Recognition of DNA by VH and Fv domains of an IgG anti-poly(dC) antibody with a singly mutated VH domain. J Mol Recognit 2001;14:18-28.
22. Wang Z, Murisiku R, Howard M, et al. Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3′ to 5′ exonuclease activity. J Immunol Methods 2000;233:167-177.
23. Marik C, Felts PA, Bauer J, et al. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 2007;130:2800-2815.
24. Kutzneligg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128:2705-2712.
25. Burgoon MP, Williamson RA, Owens GP, et al. Cloning the antibody response in humans with inflammatory CNS disease: isolation of measles virus-specific antibodies from phage display libraries of a subacute sclerosing panencephalitis brain. J Neuroimmunol 1999;94:204-211.
26. Burgoon MP, Caldas YA, Keays KM, et al. Recombinant antibodies generated from both clonal and less abundant plasma cell IgG sequences in SSPE brain are directed against measles virus. J Neurovirol 2006;12:398-402.
27. Bennett JL, Haubold K, Ritchie AM, et al. CSF IgG heavychain bias in patients at the time of a clinically isolated syndrome. J Neuroimmunol 2008:199:126-132.
28. Reindl M, Linington C, Brehm U, et al. Antibodies against the myelin oligodendrocyte glycoprotein and myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 1999;22:2047-2056.
29. Lampasona V, Franciotta D, Furlan R, et al. Similar low frequency of anti-MOG and IgM in MS patients and healthy subjects. Neurology 2004;62:2092-2094.
30. Zhou D, Srivastava R, Nessler S, et al. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci U S A 2006;103:19057-19062.
31. Lalive PH, Mengue T, Delarasse C, et al. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc Natl Acad Sci U S A 2006;103:2280-2285.
32. Berger T, Rubner P, Schautzer F, et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 2003;349:139-145.
33. Kuhle J, Pohl C, Mehling M, et al. Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med 2007;356:371-378.
34. O'Connor KC, Chitnis T, Griffin DE, et al. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions. J Neuroimmunol 2003;136:140-148.
35. O'Connor KC, McLaughlin KA, DeJager PL, et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 2007;13:211-217.
36. Lambracht-Washington D, O'Connor KC, Jowdry A, et al. Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS. J Neuroimmunol 2007;186:164-176.
37. von Büdingen H-C, Harrer MD, Kuenzle S, et al. Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies. Eur J Immunol 2008;38:2014-2023.
38. Genain C, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 1999;5:170-175.
39. Reder AT, Oger JJ. Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis. Neurology 2004;62:1922-1923.
40. Bernasconi N, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002;298:2199-2202.
41. Breij ECW, Brink BP, Veerhuis R, et al. Homogeneity of active demyelinating lesions in established MS patients. Ann Neurol 2008;63:16-25.
42. Hauser SL, Waubant E, Arnold DL, et al. B cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008;358:676-688.
43. Bar-Or A, Calabresi PAJ, Arnold D, et al. Rituximab in relapsing-remitting multiple sclerosis: a 72-week open-label, phase 1 trial. Ann Neurol 2008;63:395-400.
44. Ousman SS, Tamooka BH, van Noort J, et al. Protective and therapeutic role for αB-crystallin in autoimmune demyelination. Nature 2007;448:474-479.
45. Mathey EK, Derfuss T, Storch MK, et al. Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med 2007;204:2363-2372.
46. Ascherio A, Munger KL. Environment risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007;61:288-289.
47. Sotelo J, Martinez-Palomo A, Ordoñez G, Pineda B. Varicellazoster virus in cerebrospinal fluid at relapses of multiple sclerosis. Ann Neurol 2008;63:303-311.
48. Burgoon MP, Cohrs RJ, Bennett JL, et al. Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis. Ann Neurol 2009;65:474-479.
49. Cepok S, Zhou D, Srivastava R, et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005;115:1352-1360.
50. Serafini B, Rosicarelli B, Franciotta D, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007;204:2899-2912.